Evolus (EOLS) Interest & Investment Income (2018 - 2026)
Evolus (EOLS) reported Interest & Investment Income of $285000.0 for Q1 2026, down 59.86% on a YoY basis from $710000.0 in Q1 2025, and up 8.37% quarter-over-quarter from $263000.0 in Q4 2025.
Evolus (EOLS) Interest & Investment Income (2018 - 2026) Analysis & Trends
Evolus has reported Interest & Investment Income for 9 years, with the latest figure at $285000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 59.86% year-over-year to $285000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 56.42% YoY), and the FY2025 full-year result was $1.9 million, down 40.82% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $285000.0, up from $263000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.0 million in Q2 2024, with the low at $4000.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $403625.0 across 5 years, with a median of $298500.0 in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income surged 4000.0% — and 2025, when it slumped 66.67%.
- Evolus' Interest & Investment Income stood at $77000.0 in 2022, then soared by 277.92% to $291000.0 in 2023, then jumped by 171.13% to $789000.0 in 2024, then slumped by 66.67% to $263000.0 in 2025, then advanced by 8.37% to $285000.0 in 2026.
- The last three Interest & Investment Income figures came in at $285000.0 (Q1 2026), $263000.0 (Q4 2025), and $479000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn | 285,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,000.00 |
| Dec 31, 2025 | 263,000.00 |
| Sep 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 710,000.00 |
| Dec 31, 2024 | 789,000.00 |
| Sep 30, 2024 | 928,000.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 291,000.00 |
| Sep 30, 2023 | 306,000.00 |
| Jun 30, 2023 | 164,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 77,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 32,000.00 |
| Jun 30, 2020 | 224,000.00 |